vimarsana.com
Home
Live Updates
Phase 2,3 trial data of India's first mRNA COVID vaccine sub
Phase 2,3 trial data of India's first mRNA COVID vaccine sub
Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI: Report
Pune-based Gennova Biopharmaceuticals has also developed an Omicron-specific vaccine which will be tested on humans for efficacy and immunogenicity.
Related Keywords
,
Pune Based Gennova Biopharmaceuticals ,
Amrna Covid Vaccine ,
Gennova Biopharmaceuticals ,
Covid Vaccine ,
Coronavirus Infectio ,
Covid 19pandmeic ,
Drugs Controller General Of India Dcgi ,
Precaution Dose ,
Mrna Vaccine ,
Niti Aayog ,
Omicron Specific Vaccine ,
Omicron Variant ,
Omicron Cases ,
Covid Cases ,
Indian Council Of Medical Research Icmr ,
Balram Bhargava ,